Skip to main content
. 2022 Jun 13;11(7):e220062. doi: 10.1530/EC-22-0062

Table 1.

Comparison of patient and tumor characteristics, including preoperative biochemical laboratory values, in patients with parathyroid carcinoma and parathyroid adenoma.

Variables Carcinoma (n  = 36) Adenoma (n  = 50) P - value
Age (years) 55.0 (46–68.5) 59.5 (46–68) 0.8679
Gender (male/female) 10/26 (27.8/72.2) 15/35 (30.0/70.0) 0.8228
Tumor size (mm) 29 (18–36) 17 (14–24) 0.0002
Intact PTH level (pg/mL) 246.5 (160.0–444.5) 161.0 (118.0–205.5) 0.0003
Calcium level (mg/dL) 11.5 (10.9–12.8) 10.9 (10.6–11.3) 0.0048
Creatinine (mg/dL) 0.74 (0.60–0.90) 0.76 (0.57–0.86) 0.6455
ALP (U/L) 350 (218–512) 294 (234–386) 0.3416
WBC (/μL) 5960 (4880–6900) 5490 (4743–6605) 0.3416
Neutrophils (/μL) 3648 (2936–4384) 3231 (2698–4207) 0.1415
Lymphocytes (/μL) 1784 (1430–2346) 1789 (1475–2076) 0.8233
Monocytes (/μL) 372 (325–479) 292 (259–352) 0.0003
Plt (×104/μL) 23.1 (20.1–28.5) 24.8 (20.6–27.9) 0.7109
NLR 1.90 (1.64–2.46) 1.89 (1.48–2.22) 0.4023
PLR 141.1 (103.6–160.4) 143.4 (110.4–164.8) 0.6418
LMR 4.54 (3.38–6.28) 6.00 (4.40–7.50) 0.0062

Data were expressed as number (%) or median (interquartile range/IQR). Bold indicates statistical significance, P < 0.05. Normal range; intact PTH: 15–65 pg/mL, calcium: 8.5–10.0 mg/dL, creatinine: 0.46–1.09 mg/dL, ALP: 38–113 U/L.

ALP, alkaline phosphatase; cLND, central lymph node dissection; hTx, hemithyroidectomy; NLR, neutrophil-to-lymphocyte ratio; PTH, parathyroid hormone; Plt, platelet count; PLR, platelet-to-lymphocyte ratio; PTx, parathyroidectomy; LMR, lymphocyte-to-monocyte ratio; WBC, white blood cell.